Clinical Research Directory
Browse clinical research sites, groups, and studies.
Back to Studies
RECRUITING
NCT04295486
PHASE2
Optimal Dosing For Low-Dose Aspirin Chemoprophylaxis For VTE Following Total Joint Arthroplasty
Sponsor: University of Miami
View on ClinicalTrials.gov
Summary
This research study is attempting to answer the question of whether 81 mg aspirin once daily is as effective as 81 mg aspirin twice daily in preventing blood clots after total joint replacement surgery.
Official title: Optimal Dosing For Low-Dose Aspirin Chemoprophylaxis For Venous Thromboembolism (VTE) Following Total Joint Arthroplasty - A Multi-center Prospective Randomized Control Trial.
Key Details
Gender
All
Age Range
19 Years - Any
Study Type
INTERVENTIONAL
Enrollment
5478
Start Date
2021-03-01
Completion Date
2027-03-01
Last Updated
2026-03-11
Healthy Volunteers
No
Conditions
Interventions
DRUG
Aspirin
Non-enteric coated 81 mg Aspirin tablet.
Locations (1)
University of Miami Hospital
Miami, Florida, United States